Center for Stem Cell and Regenerative Medicine Home CSCRM - Who We Are CSCRM - Events CSCRM - News & Publications CSCRM - Research CSCRM - Commercialization
CSCRM - Education CSCRM - Membership CSCRM - Career Opportunities CSCRM - Links CSCRM

Case Western Reserve University
Cleveland Clinic
University Hospitals Case Medical Center
The Ohio State UniversityAthersys Inc.

 


The Web CSCRM Site

Google

Commercialization

The Center for Stem Cell and Regenerative Medicine has had five new business formations since its inception in 2003. Four are continuing operations.

  • Arteriocyte, Inc. (Jan. 2004) use of stem cell technology to increase blood flow with initial focus on cardiovascular applications.
  • AcelleRX Therapeutics (Sept. 2004) use of molecular cues and stem cells to increase myocardial repair after myocardial infarction.
  • Cell Targeting, Inc. (Nov. 2004) use of transient molecular markers to direct cell homing.
  • Invenio Therapeutics, Inc. (June 2007) drug that terminally differentiates leukemia cells.

For more information on these companies, please click on the company names above or send an email to stemcellcenter@case.edu.

For Stem Cell Center commercialization, licensing and/or partnership opportunities, please call Debra Grega at 216.386.3614 or send an email to stemcellcenter@case.edu.